Farmacéutica
405 empresas de esta industria que cotizan en EE. UU.
Empresas
405 listadas
| Empresa | Ingresos | Utilidad neta | Margen | ROE | Ingresos 5a | Años |
|---|---|---|---|---|---|---|
| JNJJOHNSON & JOHNSON | $94,19 mil mill. | $26,80 mil mill. | 28.5% | 35.0% | +2.7% | 19 |
| LLYELI LILLY & Co | $65,18 mil mill. | $20,64 mil mill. | 31.7% | 101.2% | +21.6% | 19 |
| MRKMerck & Co., Inc. | $65,01 mil mill. | $18,25 mil mill. | 28.1% | 36.9% | +9.4% | 19 |
| PFEPFIZER INC | $62,58 mil mill. | $7,77 mil mill. | 12.5% | 8.9% | +8.5% | 19 |
| ABBVAbbVie Inc. | $61,16 mil mill. | $4,23 mil mill. | 6.9% | · | +6.0% | 15 |
| AZNASTRAZENECA PLC | $58,74 mil mill. | $10,22 mil mill. | 17.4% | 22.9% | +17.2% | 11 |
| NVSNOVARTIS AG | $54,53 mil mill. | $13,98 mil mill. | 25.6% | 31.0% | +2.3% | 10 |
| BMYBRISTOL MYERS SQUIBB CO | $48,19 mil mill. | $7,05 mil mill. | 14.6% | 40.5% | +2.5% | 19 |
| ABTABBOTT LABORATORIES | $44,33 mil mill. | $6,52 mil mill. | 14.7% | 13.1% | +5.1% | 19 |
| TEVATEVA PHARMACEUTICAL INDUSTRIES LTD | $17,26 mil mill. | $1,41 mil mill. | 8.2% | 21.2% | +0.7% | 17 |
| REGNREGENERON PHARMACEUTICALS, INC. | $14,34 mil mill. | $4,50 mil mill. | 31.4% | 14.9% | +11.0% | 18 |
| VTRSViatris Inc | $14,30 mil mill. | -$3,51 mil mill. | -24.6% | · | +3.7% | 8 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | $12,00 mil mill. | $3,95 mil mill. | 32.9% | 22.5% | +14.1% | 18 |
| BHCBausch Health Companies Inc. | $10,27 mil mill. | $157,0 mill. | 1.2% | · | +5.0% | 18 |
| ZTSZoetis Inc. | $9,47 mil mill. | $2,67 mil mill. | 28.2% | 66.0% | +7.2% | 15 |
| OGNOrganon & Co. | $6,22 mil mill. | $187,0 mill. | 3.0% | 30.6% | -1.0% | 7 |
| ONCBeOne Medicines Ltd. | $5,34 mil mill. | $286,9 mill. | 5.4% | 7.5% | +76.8% | 12 |
| ELANElanco Animal Health Inc | $4,71 mil mill. | -$232,0 mill. | -4.9% | -3.7% | +7.6% | 10 |
| JAZZJazz Pharmaceuticals plc | $4,27 mil mill. | -$356,1 mill. | -8.3% | -8.5% | +12.5% | 17 |
| PRGOPERRIGO Co plc | $4,25 mil mill. | -$1,43 mil mill. | -33.5% | -39.3% | +0.8% | 14 |
| GMABGENMAB A/S | $3,72 mil mill. | $963,0 mill. | 25.9% | 4.5% | · | 6 |
| ALNYALNYLAM PHARMACEUTICALS, INC. | $3,71 mil mill. | $313,7 mill. | 8.4% | 73.3% | +49.8% | 13 |
| BMRNBIOMARIN PHARMACEUTICAL INC | $3,22 mil mill. | $348,9 mill. | 10.8% | 5.9% | +11.6% | 18 |
| UTHRUNITED THERAPEUTICS Corp | $3,18 mil mill. | $1,33 mil mill. | 41.9% | 19.7% | +16.5% | 18 |
| AMRXAmneal Pharmaceuticals, Inc. | $3,02 mil mill. | $72,1 mill. | 4.2% | · | +8.7% | 10 |
| RPRXRoyalty Pharma plc | $2,38 mil mill. | $770,9 mill. | 55.7% | 7.7% | +2.3% | 8 |
| SRPTSarepta Therapeutics, Inc. | $2,20 mil mill. | -$713,4 mill. | -32.5% | -53.5% | +32.4% | 12 |
| PTCTPTC THERAPEUTICS, INC. | $1,73 mil mill. | $682,6 mill. | 39.4% | · | +35.4% | 15 |
| PAHCPHIBRO ANIMAL HEALTH CORP | $1,52 mil mill. | $99,7 mill. | 6.6% | 29.7% | +12.7% | 15 |
| ALKSAlkermes plc. | $1,48 mil mill. | $241,7 mill. | 16.4% | 14.7% | +7.3% | 17 |
| INDVIndivior Pharmaceuticals, Inc. | $1,24 mil mill. | $210,0 mill. | 16.9% | · | · | 4 |
| PBHPrestige Consumer Healthcare Inc. | $1,09 mil mill. | $190,3 mill. | 17.5% | 10.2% | +2.9% | 17 |
| ACADACADIA PHARMACEUTICALS INC | $1,07 mil mill. | $391,0 mill. | 36.5% | 39.9% | +19.4% | 17 |
| LEGNLegend Biotech Corp | $1,03 mil mill. | -$296,8 mill. | -28.8% | -29.1% | +68.8% | 8 |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | $958,4 mill. | -$288,3 mill. | -30.1% | -42.5% | · | 10 |
| IONSIONIS PHARMACEUTICALS INC | $943,7 mill. | -$381,4 mill. | -40.4% | -70.8% | +5.3% | 18 |
| ANIPANI PHARMACEUTICALS INC | $883,4 mill. | $78,3 mill. | 8.9% | 16.6% | +33.5% | 17 |
| HRMYHarmony Biosciences Holdings, Inc. | $868,5 mill. | $158,7 mill. | 18.3% | 20.8% | +40.3% | 7 |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | $829,4 mill. | -$1,6 mill. | · | -0.5% | +56.6% | 15 |
| TLXTelix Pharmaceuticals Ltd | $803,8 mill. | -$7,1 mill. | -0.9% | -1.9% | · | 4 |
| COLLCOLLEGIUM PHARMACEUTICAL, INC | $780,6 mill. | $62,9 mill. | 8.1% | 23.7% | +20.3% | 10 |
| CORTCORCEPT THERAPEUTICS INC | $761,4 mill. | $99,7 mill. | 13.1% | 15.0% | +16.6% | 15 |
| PCRXPacira BioSciences, Inc. | $726,4 mill. | $7,0 mill. | 1.0% | 1.0% | +11.1% | 17 |
| AMPHAmphastar Pharmaceuticals, Inc. | $719,9 mill. | $98,1 mill. | 13.6% | 12.9% | +15.5% | 14 |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | $719,0 mill. | -$38,5 mill. | -5.4% | -3.7% | +6.7% | 16 |
| KNSAKiniksa Pharmaceuticals International, | $677,6 mill. | $59,0 mill. | 8.7% | 11.7% | · | 5 |
| RAREUltragenyx Pharmaceutical Inc. | $673,0 mill. | -$575,0 mill. | -85.4% | · | +19.9% | 10 |
| AXSMAxsome Therapeutics, Inc. | $638,5 mill. | -$183,2 mill. | -28.7% | -252.1% | · | 4 |
| TGTXTG THERAPEUTICS, INC. | $616,3 mill. | $447,2 mill. | 72.6% | 102.8% | +426.7% | 10 |
| INSMINSMED Inc | $606,4 mill. | -$1,28 mil mill. | -210.5% | -249.3% | +29.8% | 16 |
| HCMHUTCHMED (China) Ltd | $548,5 mill. | $456,9 mill. | 83.4% | 45.7% | +19.2% | 12 |
| MIRMMirum Pharmaceuticals, Inc. | $521,3 mill. | -$23,4 mill. | -4.5% | -8.6% | · | 6 |
| BBIOBridgeBio Pharma, Inc. | $502,1 mill. | -$732,9 mill. | -146.0% | · | +127.4% | 7 |
| TVTXTravere Therapeutics, Inc. | $490,7 mill. | -$25,5 mill. | -5.2% | -29.4% | +19.9% | 15 |
| ZLABZai Lab Ltd | $460,2 mill. | -$175,5 mill. | -38.1% | -22.6% | +56.5% | 8 |
| INVAInnoviva, Inc. | $411,3 mill. | $271,2 mill. | 65.9% | 29.1% | +4.1% | 17 |
| ARDXARDELYX, INC. | $407,3 mill. | -$61,6 mill. | -15.1% | -36.2% | +121.9% | 13 |
| ARQTArcutis Biotherapeutics, Inc. | $376,1 mill. | -$16,1 mill. | -4.3% | -9.3% | · | 6 |
| MNKDMANNKIND CORP | $349,0 mill. | $5,9 mill. | 1.7% | · | +39.9% | 16 |
| XERSXeris Biopharma Holdings, Inc. | $291,8 mill. | $554.000 | 0.2% | · | +70.2% | 6 |
| AUPHAurinia Pharmaceuticals Inc. | $283,1 mill. | $287,2 mill. | 101.5% | 59.9% | +41.4% | 8 |
| HROWHARROW, INC. | $272,3 mill. | -$5,1 mill. | -1.9% | -8.4% | +41.0% | 13 |
| LGNDLIGAND PHARMACEUTICALS INC | $268,1 mill. | $124,5 mill. | 46.4% | 13.5% | +10.4% | 17 |
| SDGRSchrodinger, Inc. | $255,9 mill. | -$103,3 mill. | -40.4% | -26.3% | +18.8% | 7 |
| RCUSArcus Biosciences, Inc. | $247,0 mill. | -$353,0 mill. | -142.9% | -63.3% | +25.9% | 9 |
| AKBAAkebia Therapeutics, Inc. | $236,2 mill. | -$5,3 mill. | -2.3% | · | -4.3% | 12 |
| IDYAIDEAYA Biosciences, Inc. | $218,7 mill. | -$113,7 mill. | -52.0% | -10.9% | +62.1% | 7 |
| RYTMRHYTHM PHARMACEUTICALS, INC. | $189,8 mill. | -$196,5 mill. | -103.6% | -244.5% | · | 10 |
| SNDXSyndax Pharmaceuticals Inc | $172,4 mill. | -$285,4 mill. | -165.6% | -161.8% | · | 11 |
| CYTKCYTOKINETICS INC | $88,0 mill. | -$785,0 mill. | -891.6% | · | +9.5% | 17 |
| NRIXNurix Therapeutics, Inc. | $84,0 mill. | -$264,5 mill. | -314.9% | -49.6% | +36.3% | 7 |
| ABCLAbCellera Biologics Inc. | $75,1 mill. | -$146,4 mill. | -194.9% | -14.5% | -20.3% | 7 |
| VRDNViridian Therapeutics, Inc.\DE | $70,8 mill. | -$342,6 mill. | · | -49.2% | +132.2% | 13 |
| AGIOAGIOS PHARMACEUTICALS, INC. | $54,0 mill. | -$412,8 mill. | -764.0% | -30.2% | · | 15 |
| OCULOCULAR THERAPEUTIX, INC | $52,0 mill. | -$265,9 mill. | -511.9% | -54.9% | +24.4% | 13 |
| PTGXProtagonist Therapeutics, Inc | $46,0 mill. | -$130,1 mill. | -282.8% | -20.2% | +10.0% | 9 |
| WVEWave Life Sciences, Inc. | $42,7 mill. | -$204,4 mill. | -478.3% | -56.2% | +16.3% | 11 |
| NAMSNewAmsterdam Pharma Co N.V. | $22,5 mill. | -$203,8 mill. | -905.7% | -28.3% | · | 4 |
| QUREuniQure N.V. | $16,1 mill. | -$199,0 mill. | -1236.0% | · | -15.6% | 12 |
| JANXJanux Therapeutics, Inc. | $10,0 mill. | -$113,6 mill. | -1136.2% | -11.5% | · | 6 |
| ROIVRoivant Sciences Ltd. | $8,3 mill. | -$299,8 mill. | · | -6.5% | · | 6 |
| CRNXCrinetics Pharmaceuticals, Inc. | $7,7 mill. | -$465,3 mill. | · | -40.2% | +155.3% | 10 |
| XENEXenon Pharmaceuticals Inc. | $7,5 mill. | -$345,9 mill. | · | -51.8% | · | 13 |
| PRAXPraxis Precision Medicines, Inc. | $0 | -$303,3 mill. | · | -45.8% | · | 4 |
| SYRESpyre Therapeutics, Inc. | $0 | -$155,2 mill. | · | -25.2% | · | 10 |
| VKTXViking Therapeutics, Inc. | $0 | -$359,6 mill. | · | -47.3% | · | 12 |
| TAKTAKEDA PHARMACEUTICAL CO LTD | JPY 4,58 billones | JPY 107,93 mil mill. | 2.4% | 1.5% | +6.8% | 9 |
| RDYDR REDDYS LABORATORIES LTD | INR 325,54 mil mill. | INR 56,54 mil mill. | 17.6% | 18.4% | +13.3% | 10 |
| NVONOVO NORDISK A S | DKK 309,06 mil mill. | DKK 102,43 mil mill. | 33.1% | 60.7% | +19.5% | 7 |
| SNYSanofi | EUR 43,63 mil mill. | EUR 7,81 mil mill. | 18.0% | 10.5% | +3.9% | 11 |
| GSKGSK plc | GBP 32,67 mil mill. | GBP 5,72 mil mill. | 19.3% | 38.0% | +6.0% | 11 |
| GRFSGrifols SA | EUR 7,21 mil mill. | EUR 156,9 mill. | 3.0% | 2.8% | +7.2% | 10 |
| LKFTLakefront Biotherapeutics NV | EUR 1,11 mil mill. | EUR 320,9 mill. | 28.8% | 10.5% | +18.4% | 11 |
| EVOEvotec SE | EUR 797,0 mill. | -EUR 196,1 mill. | -24.6% | -18.9% | +12.3% | 6 |
| ASNDAscendis Pharma A/S | EUR 720,1 mill. | -EUR 228,0 mill. | -31.7% | · | +153.0% | 11 |
| COGTCogent Biosciences, Inc. | · | -$328,9 mill. | · | -73.7% | · | 4 |
| GERNGERON CORP | · | -$83,5 mill. | · | -33.0% | · | 15 |
| MLTXMoonLake Immunotherapeutics | · | -$227,3 mill. | · | -60.5% | · | 0 |
| PHVSPharvaris N.V. | · | -EUR 175,7 mill. | · | -65.2% | · | 0 |
| SMMTSummit Therapeutics Inc. | · | -$1,08 mil mill. | · | -206.1% | · | 6 |
| EBSEmergent BioSolutions Inc. | $742,9 mill. | $52,6 mill. | 7.1% | 10.5% | -14.0% | 17 |
| OPKOPKO HEALTH, INC. | $606,9 mill. | -$225,7 mill. | -37.2% | -17.1% | -15.8% | 17 |
| ORGOOrganogenesis Holdings Inc. | $564,2 mill. | $37,0 mill. | 6.6% | 13.2% | +10.8% | 10 |
| NATRNATURES SUNSHINE PRODUCTS INC | $480,1 mill. | $19,5 mill. | 4.3% | 12.1% | +4.5% | 17 |
| SVASINOVAC BIOTECH LTD | $386,0 mill. | -$198,8 mill. | -51.5% | · | -5.4% | 17 |
| PHARPharming Group N.V. | $376,1 mill. | $2,9 mill. | 0.7% | 1.1% | +12.1% | 8 |
| EOLSEvolus, Inc. | $297,2 mill. | -$51,6 mill. | -17.4% | · | +39.4% | 8 |
| IRWDIRONWOOD PHARMACEUTICALS INC | $296,2 mill. | $24,0 mill. | 8.1% | · | -5.3% | 17 |
| RIGLRIGEL PHARMACEUTICALS INC | $294,3 mill. | $367,0 mill. | 124.7% | 185.9% | +22.1% | 10 |
| ARVNARVINAS, INC. | $262,6 mill. | -$80,8 mill. | -30.8% | -16.2% | +58.9% | 9 |
| PBYIPUMA BIOTECHNOLOGY, INC. | $228,4 mill. | $31,1 mill. | 13.6% | 28.0% | +0.3% | 9 |
| VNDAVanda Pharmaceuticals Inc. | $216,1 mill. | -$220,5 mill. | -102.0% | -50.9% | -2.7% | 17 |
| AMRNAMARIN CORP PLC\UK | $213,6 mill. | -$38,8 mill. | -18.2% | -8.2% | -19.0% | 13 |
| MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. | $185,7 mill. | -$130,8 mill. | -124.2% | -48.6% | -8.1% | 7 |
| LFVNLifevantage Corp | $182,6 mill. | $5,1 mill. | · | 14.9% | -3.7% | 16 |
| KMDAKAMADA LTD | $180,5 mill. | $20,2 mill. | 11.2% | 7.6% | +6.3% | 11 |
| CYRXCryoport, Inc. | $176,2 mill. | $78,3 mill. | 44.4% | 17.3% | +17.5% | 16 |
| HRTXHERON THERAPEUTICS, INC. | $154,9 mill. | -$20,2 mill. | -13.0% | · | +11.8% | 10 |
| LFCRLIFECORE BIOMEDICAL, INC. \DE\ | $128,9 mill. | -$38,7 mill. | -30.0% | -612.1% | · | 16 |
| XNCRXencor Inc | $125,6 mill. | -$91,9 mill. | -73.4% | -14.0% | +0.5% | 10 |
| GYREGYRE THERAPEUTICS, INC. | $116,6 mill. | $9,9 mill. | 8.5% | 11.7% | +41.0% | 14 |
| SIGASIGA TECHNOLOGIES INC | $94,6 mill. | $23,3 mill. | 24.6% | 11.2% | -5.4% | 10 |
| LABSTANDARD BIOTOOLS INC. | $85,3 mill. | -$74,9 mill. | -87.8% | -16.7% | -9.2% | 17 |
| ARCTArcturus Therapeutics Holdings Inc. | $82,0 mill. | -$65,8 mill. | -80.2% | -28.9% | +53.8% | 8 |
| CTMXCytomX Therapeutics, Inc. | $76,2 mill. | -$17,4 mill. | -22.8% | · | +2.2% | 13 |
| ADAGAdagene Inc. | $7,7 mill. | -$17,6 mill. | · | -41.0% | +61.4% | 8 |
| PTCHFPureTech Health plc | $4,8 mill. | $53,5 mill. | 575.4% | 12.2% | -13.2% | 7 |
| NBTXNanobiotix S.A. | EUR 32,6 mill. | -EUR 24,0 mill. | -73.5% | · | +67.0% | 8 |
| PRQRProQR Therapeutics N.V. | EUR 15,9 mill. | -EUR 42,2 mill. | -265.2% | -61.2% | · | 5 |
| IMMPIMMUTEP Ltd | AUD 10,3 mill. | -AUD 61,4 mill. | -594.6% | -36.9% | -8.9% | 10 |
| IVAInventiva S.A. | EUR 9,2 mill. | -EUR 184,2 mill. | · | · | +5.6% | 7 |
| ACIUAC Immune SA | CHF 3,6 mill. | -CHF 70,4 mill. | · | -89.7% | · | 11 |
| PRTAPROTHENA CORP PUBLIC LTD CO | · | -$244,1 mill. | · | -63.6% | · | 10 |
| UPCUniverse Pharmaceuticals INC | $17,86 mil mill. | -$3,67 mil mill. | -20.6% | -7.2% | +257.2% | 7 |
| CRMDCorMedix Inc. | $311,7 mill. | $163,1 mill. | 52.3% | 66.6% | · | 13 |
| KROSKeros Therapeutics, Inc. | $244,1 mill. | $87,0 mill. | 35.7% | 19.9% | · | 7 |
| ANABANAPTYSBIO, INC | $234,6 mill. | -$13,2 mill. | -5.6% | -24.5% | +25.6% | 11 |
| STOKStoke Therapeutics, Inc. | $184,4 mill. | -$6,9 mill. | -3.7% | -2.4% | · | 4 |
| PHATPhathom Pharmaceuticals, Inc. | $175,1 mill. | -$221,2 mill. | -126.3% | · | · | 4 |
| LQDALiquidia Corp | $158,3 mill. | -$68,9 mill. | -43.5% | -111.1% | +192.5% | 7 |
| MGNXMACROGENICS INC | $149,5 mill. | -$74,6 mill. | -49.9% | -86.9% | +7.3% | 15 |
| ELTPELITE PHARMACEUTICALS INC | $148,9 mill. | $44,9 mill. | 30.1% | 58.9% | +42.4% | 16 |
| KPTIKaryopharm Therapeutics Inc. | $146,1 mill. | -$196,0 mill. | -134.2% | · | +6.2% | 15 |
| URGNUroGen Pharma Ltd. | $109,8 mill. | -$153,5 mill. | -139.8% | · | +56.2% | 10 |
| TBPHTheravance Biopharma, Inc. | $107,5 mill. | $105,9 mill. | 98.5% | 44.8% | +8.4% | 14 |
| ZVRAZEVRA THERAPEUTICS, INC. | $106,5 mill. | $83,2 mill. | 78.2% | 85.7% | +51.6% | 11 |
| ZYMEZymeworks Inc. | $106,0 mill. | -$81,1 mill. | -76.6% | -26.7% | +22.2% | 6 |
| SPRYARS Pharmaceuticals, Inc. | $84,3 mill. | -$171,3 mill. | -203.3% | -92.3% | · | 5 |
| ADCTADC Therapeutics SA | $81,4 mill. | -$142,6 mill. | -175.3% | · | · | 4 |
| ETONEton Pharmaceuticals, Inc. | $80,0 mill. | -$4,6 mill. | -5.8% | -18.2% | +359.6% | 7 |
| BCYCBICYCLE THERAPEUTICS PLC | $72,6 mill. | -$219,0 mill. | -301.7% | -31.2% | +47.5% | 9 |
| ASMBASSEMBLY BIOSCIENCES, INC. | $72,3 mill. | -$6,1 mill. | -8.5% | -5.1% | · | 10 |
| RMTIROCKWELL MEDICAL, INC. | $69,3 mill. | -$5,3 mill. | -7.7% | -15.3% | +2.2% | 17 |
| KURAKura Oncology, Inc. | $67,5 mill. | -$278,7 mill. | -412.9% | -94.8% | · | 3 |
| SPROSpero Therapeutics, Inc. | $66,8 mill. | $8,6 mill. | 12.8% | 16.3% | +48.2% | 10 |
| ENTAENANTA PHARMACEUTICALS INC | $65,3 mill. | -$81,9 mill. | -125.4% | -84.6% | -11.8% | 15 |
| FBIOFortress Biotech, Inc. | $63,3 mill. | $6,8 mill. | -52.0% | 18.8% | +6.8% | 13 |
| NUVBNuvation Bio Inc. | $62,9 mill. | -$204,6 mill. | -325.3% | -53.2% | · | 3 |
| TNGXTango Therapeutics, Inc. | $62,4 mill. | -$101,6 mill. | -162.9% | -37.2% | +52.1% | 6 |
| DERMJourney Medical Corp | $61,9 mill. | -$11,4 mill. | -18.5% | -44.0% | +6.8% | 6 |
| AYTUAYTU BIOPHARMA, INC | $57,6 mill. | -$14,3 mill. | -24.8% | -52.6% | -2.6% | 14 |
| NKTRNEKTAR THERAPEUTICS | $55,2 mill. | -$164,1 mill. | -297.1% | -217.9% | -18.4% | 17 |
| QTTBQ32 Bio Inc. | $53,7 mill. | $29,8 mill. | 55.5% | 125.1% | · | 8 |
| LXRXLEXICON PHARMACEUTICALS, INC. | $49,8 mill. | -$50,3 mill. | -101.1% | -39.7% | +15.7% | 17 |
| GOSSGossamer Bio, Inc. | $48,5 mill. | -$170,4 mill. | -351.5% | · | · | 4 |
| AQSTAquestive Therapeutics, Inc. | $44,5 mill. | -$83,8 mill. | -188.1% | · | -0.6% | 9 |
| CPIXCUMBERLAND PHARMACEUTICALS INC | $44,5 mill. | -$2,8 mill. | -6.4% | -11.9% | +3.5% | 17 |
| INBPINTEGRATED BIOPHARMA INC | $43,9 mill. | -$2,8 mill. | -6.5% | -15.0% | -7.1% | 16 |
| BGMBGM Group Ltd. | $37,9 mill. | -$19,9 mill. | -53.3% | -9.2% | -5.4% | 8 |
| LIFDLFTD PARTNERS INC. | $36,9 mill. | -$24,9 mill. | -67.3% | -99.2% | +47.2% | 10 |
| SBFMSunshine Biopharma Inc. | $36,3 mill. | -$6,0 mill. | -16.5% | -25.7% | +247.7% | 16 |
| ETSTEarth Science Tech, Inc. | $35,7 mill. | $3,6 mill. | · | 66.9% | +202.5% | 13 |
| VRCAVerrica Pharmaceuticals Inc. | $35,6 mill. | -$17,9 mill. | -50.3% | · | · | 5 |
| ZOMDFZomedica Corp. | $32,0 mill. | -$81,9 mill. | -255.6% | -52.6% | · | 6 |
| VSTMVerastem, Inc. | $30,9 mill. | -$209,5 mill. | -677.6% | · | · | 7 |
| FHTXFoghorn Therapeutics Inc. | $30,9 mill. | -$74,3 mill. | -240.3% | · | +135.1% | 6 |
| PREPrenetics Global Ltd | $30,6 mill. | -$46,3 mill. | -162.7% | -24.6% | · | 5 |
| CUECue Biopharma, Inc. | $27,5 mill. | -$26,6 mill. | -96.9% | -121.1% | +54.2% | 8 |
| CELUCelularity Inc | $26,6 mill. | -$91,7 mill. | -345.4% | · | +13.2% | 6 |
| CASIFCASI Pharmaceuticals, Inc. | $20,7 mill. | -$48,1 mill. | -232.0% | · | +6.5% | 6 |
| SCYXSCYNEXIS INC | $20,6 mill. | -$8,6 mill. | -41.8% | -16.5% | · | 13 |
| EVFMEvofem Biosciences, Inc. | $20,2 mill. | $391.000 | 1.9% | · | +114.4% | 7 |
| SLGLSol-Gel Technologies Ltd. | $19,4 mill. | -$6,1 mill. | -31.6% | -23.7% | +17.2% | 9 |
| IRDOpus Genetics, Inc. | $14,2 mill. | -$49,6 mill. | -349.3% | -449.4% | · | 12 |
| ABUSArbutus Biopharma Corp | $14,1 mill. | -$33,5 mill. | -237.9% | -38.5% | +15.3% | 17 |
| CVSICV Sciences, Inc. | $13,8 mill. | -$958.000 | -6.9% | -58.7% | -10.8% | 14 |
| PTNPALATIN TECHNOLOGIES INC | $13,2 mill. | -$8,4 mill. | · | · | · | 16 |
| TNXPTonix Pharmaceuticals Holding Corp. | $13,1 mill. | -$124,0 mill. | -946.2% | -64.5% | · | 3 |
| EMMAEmmaus Life Sciences, Inc. | $12,5 mill. | -$7,5 mill. | -60.2% | · | -11.7% | 15 |
| JAGXJaguar Health, Inc. | $11,5 mill. | -$53,6 mill. | -469.1% | · | +4.2% | 12 |
| CBIOCRESCENT BIOPHARMA, INC. | $10,8 mill. | -$153,9 mill. | -1419.6% | · | · | 10 |
| PGENPRECIGEN, INC. | $9,7 mill. | -$250,6 mill. | · | -843.6% | -21.3% | 15 |
| ISCOInternational Stem Cell CORP | $9,1 mill. | -$418.000 | -4.6% | · | +5.0% | 16 |
| RDHLRedHill Biopharma Ltd. | $8,0 mill. | -$8,3 mill. | -102.8% | · | +5.0% | 10 |
| ACRSAclaris Therapeutics, Inc. | $7,8 mill. | -$64,9 mill. | -829.6% | -50.2% | +3.8% | 9 |
| OVIDOvid Therapeutics Inc. | $7,3 mill. | -$17,4 mill. | -240.1% | -17.5% | -10.5% | 6 |
| WHWKWhitehawk Therapeutics, Inc. | $7,1 mill. | -$20,6 mill. | -288.3% | -21.8% | -12.6% | 8 |
| KYNBKYNTRA BIO, INC. | $6,4 mill. | $183,5 mill. | · | · | · | 13 |
| KRROKorro Bio, Inc. | $6,4 mill. | -$117,3 mill. | · | -110.7% | · | 7 |
| ABEOABEONA THERAPEUTICS INC. | $5,8 mill. | $71,2 mill. | 1223.1% | 70.0% | · | 14 |
| ENSCEnsysce Biosciences, Inc. | $5,1 mill. | -$10,2 mill. | -200.8% | · | +5.2% | 6 |
| PCYNPROCYON CORP | $5,0 mill. | -$341.140 | -6.8% | -13.9% | +3.5% | 14 |
| PRPHProPhase Labs, Inc. | $4,3 mill. | -$14,7 mill. | -339.3% | -271.5% | -21.4% | 17 |
| CPHICHINA PHARMA HOLDINGS, INC. | $4,1 mill. | -$3,2 mill. | -76.9% | -20.9% | -17.5% | 16 |
| CRVOCervoMed Inc. | $4,0 mill. | -$27,0 mill. | -673.1% | -93.9% | · | 8 |
| RADXRadiopharm Theranostics Ltd | $3,6 mill. | -$38,3 mill. | -1055.3% | -109.2% | · | 3 |
| MRKRMarker Therapeutics, Inc. | $3,5 mill. | -$12,2 mill. | -343.0% | -68.8% | +48.0% | 9 |
| TXMDTherapeuticsMD, Inc. | $3,0 mill. | -$569.000 | -18.8% | -2.1% | · | 15 |
| XBIOXenetic Biosciences, Inc. | $3,0 mill. | -$2,7 mill. | -90.1% | -40.0% | +46.8% | 14 |
| RNACCartesian Therapeutics, Inc. | $2,8 mill. | -$130,3 mill. | · | · | -30.0% | 12 |
| TRAWTraws Pharma, Inc. | $2,8 mill. | $9,2 mill. | 328.7% | · | +64.6% | 15 |
| GOVXGeoVax Labs, Inc. | $2,5 mill. | -$21,5 mill. | -862.3% | -483.8% | · | 10 |
| KRSAKorsana Biosciences, Inc. | $2,1 mill. | -$3,5 mill. | -170.1% | -39.3% | · | 7 |
| DNTHDianthus Therapeutics, Inc. | $2,0 mill. | -$162,3 mill. | · | -38.4% | · | 7 |
| ORMPORAMED PHARMACEUTICALS INC. | $2,0 mill. | $64,0 mill. | · | 37.0% | · | 9 |
| LPCNLipocine Inc. | $2,0 mill. | -$9,6 mill. | -487.1% | -54.3% | · | 12 |
| BIOEBio Essence Corp | $1,9 mill. | $896.197 | · | · | +14.6% | 6 |
| RANIRani Therapeutics Holdings, Inc. | $1,6 mill. | -$29,7 mill. | · | -169.6% | · | 6 |
| NRXPNRX Pharmaceuticals, Inc. | $1,4 mill. | -$28,6 mill. | · | · | · | 3 |
| ATXIAVENUE THERAPEUTICS, INC. | $1,4 mill. | -$2,9 mill. | -209.9% | -125.7% | · | 2 |
| NWBONORTHWEST BIOTHERAPEUTICS INC | $1,4 mill. | -$60,2 mill. | · | · | +1.3% | 16 |
| CPMDCANNAPHARMARX, INC. | $1,4 mill. | -$11,1 mill. | -817.2% | · | · | 13 |
| SPRCSciSparc Ltd. | $1,3 mill. | -$6,3 mill. | -572.1% | -79.7% | · | 3 |
| IGCIGC Pharma, Inc. | $1,3 mill. | -$7,1 mill. | -560.3% | -104.3% | -20.8% | 15 |
| VTGNVistagen Therapeutics, Inc. | $1,3 mill. | -$69,7 mill. | · | -131.6% | +3.1% | 13 |
| BLRXBioLineRx Ltd. | $1,2 mill. | -$2,0 mill. | -171.7% | · | · | 5 |
| SXTCChina SXT Pharmaceuticals, Inc. | $1,1 mill. | -$6,2 mill. | -545.2% | -27.5% | -24.9% | 10 |
| DAREDare Bioscience, Inc. | $1,0 mill. | -$13,4 mill. | · | · | · | 9 |
| STTKShattuck Labs, Inc. | $1,0 mill. | -$48,8 mill. | · | -60.3% | -36.8% | 7 |
| RFLRafael Holdings, Inc. | $917.000 | -$30,5 mill. | · | -34.6% | · | 10 |
| MCRBSeres Therapeutics, Inc. | $789.000 | $5,7 mill. | 721.9% | 19.6% | · | 11 |
| LEXXLexaria Bioscience Corp. | $705.923 | -$11,9 mill. | · | -215.9% | +17.5% | 14 |
| PMHSPolomar Health Services, Inc. | $648.231 | -$10,7 mill. | · | · | · | 4 |
| BTAIQBioXcel Therapeutics, Inc. | $642.000 | -$69,9 mill. | · | · | · | 4 |
| VCNXVACCINEX, INC. | $601.000 | -$18,6 mill. | · | · | +2.8% | 8 |
| YARWYarrow Bioscience, Inc. | $570.000 | -$26,5 mill. | · | -66.3% | -51.4% | 10 |
| SLNSilence Therapeutics plc | $559.000 | -$88,6 mill. | · | -90.3% | · | 4 |
| SCNXScienture Holdings, Inc. | $431.609 | -$41,5 mill. | · | -55.6% | · | 13 |
| MNOVMEDICINOVA INC | $409.657 | -$12,0 mill. | · | -25.5% | · | 5 |
| CANFCan-Fite BioPharma Ltd. | $405.000 | -$9,8 mill. | · | -178.2% | -11.9% | 8 |
| AAGHAmerica Great Health | $391.743 | -$719.119 | -184.1% | · | +134.9% | 13 |
| PVCTPROVECTUS BIOPHARMACEUTICALS, INC. | $336.108 | -$5,4 mill. | · | · | · | 9 |
| ABVCABVC BIOPHARMA, INC. | $296.000 | -$7,9 mill. | · | -128.2% | -9.3% | 14 |
| RGBPRegen BioPharma Inc | $236.561 | -$1,3 mill. | -538.8% | · | +16.5% | 12 |
| CLNNClene Inc. | $200.000 | -$26,2 mill. | · | · | -0.6% | 6 |
| LSTALISATA THERAPEUTICS, INC. | $170.000 | -$16,6 mill. | · | -74.7% | · | 11 |
| SERSerina Therapeutics, Inc. | $130.000 | -$19,2 mill. | · | · | -18.5% | 9 |
| IBIOiBio, Inc. | $100.000 | -$33,0 mill. | · | -65.7% | · | 16 |
| ATNMActinium Pharmaceuticals, Inc. | $90.000 | -$33,9 mill. | · | -167.0% | · | 6 |
| SILOSilo Pharma, Inc. | $72.102 | -$4,2 mill. | · | -74.6% | · | 6 |
| INOINOVIO PHARMACEUTICALS, INC. | $65.343 | -$84,9 mill. | · | -183.5% | -61.2% | 17 |
| AVTXAvalo Therapeutics, Inc. | $59.000 | -$78,3 mill. | · | -72.4% | -61.2% | 11 |
| LNAILunai Bioworks Inc. | $51.992 | -$3,6 mill. | · | · | · | 5 |
| ALTAltimmune, Inc. | $41.000 | -$88,1 mill. | · | -50.6% | -65.3% | 12 |
| AXIMAXIM BIOTECHNOLOGIES, INC. | $39.518 | -$8,1 mill. | · | · | · | 13 |
| LYELLyell Immunopharma, Inc. | $36.000 | -$274,4 mill. | · | -87.0% | -65.9% | 7 |
| TLPHTALPHERA, INC. | $28.000 | -$14,3 mill. | · | -114.2% | · | 15 |
| SKVISKINVISIBLE, INC. | $20.000 | -$1,1 mill. | · | · | -33.4% | 16 |
| BDPTBIOADAPTIVES, INC. | $18.278 | -$1,6 mill. | · | · | +2.3% | 7 |
| PRFXPRF Technologies Ltd. | $17.000 | -$5,0 mill. | · | -96.9% | · | 3 |
| GNLXGENELUX Corp | $8.000 | -$32,1 mill. | · | -170.0% | · | 4 |
| TCRTAlaunos Therapeutics, Inc. | $5.000 | -$4,2 mill. | · | -198.1% | · | 11 |
| OWPCOne World Products, Inc. | $4.863 | -$3,9 mill. | · | · | · | 5 |
| ADTXAditxt, Inc. | $3.195 | -$43,1 mill. | · | -1183.4% | · | 5 |
| AMLXAmylyx Pharmaceuticals, Inc. | $0 | -$144,7 mill. | · | -61.6% | · | 5 |
| ANVSAnnovis Bio, Inc. | $0 | -$28,9 mill. | · | -220.6% | · | 6 |
| APLMApollomics Inc. | $0 | -$53,9 mill. | · | -233.7% | · | 5 |
| BYSIBeyondSpring Inc. | $0 | -$1,0 mill. | · | · | · | 12 |
| CAPRCAPRICOR THERAPEUTICS, INC. | $0 | -$105,0 mill. | · | -46.6% | · | 15 |
| DSGNDesign Therapeutics, Inc. | $0 | -$69,8 mill. | · | -30.7% | · | 3 |
| FULCFulcrum Therapeutics, Inc. | $0 | -$74,9 mill. | · | -25.3% | · | 6 |
| HSTCHST Global, Inc. | $0 | -$146.210 | · | · | · | 7 |
| HURATuHURA Biosciences, Inc. | $0 | -$30,1 mill. | · | -169.2% | · | 5 |
| IXHLIncannex Healthcare Inc. | $0 | -$19,3 mill. | · | -47.8% | · | 3 |
| KALAKALA BIO, Inc. | $0 | -$27,0 mill. | · | -279.2% | · | 10 |
| KPRXKIORA PHARMACEUTICALS INC | $0 | -$10,8 mill. | · | -51.7% | · | 10 |
| MBRXMoleculin Biotech, Inc. | $0 | -$33,6 mill. | · | -256.0% | · | 10 |
| MNPRMonopar Therapeutics | $0 | -$13,7 mill. | · | -14.2% | · | 6 |
| NGNENeurogene Inc. | $0 | -$90,4 mill. | · | -31.4% | · | 4 |
| NKTXNkarta, Inc. | $0 | -$104,1 mill. | · | -28.9% | · | 3 |
| NNVCNANOVIRICIDES, INC. | $0 | -$8,2 mill. | · | -101.5% | · | 4 |
| PLRXPLIANT THERAPEUTICS, INC. | $0 | -$149,3 mill. | · | -61.5% | · | 7 |
| PTIXProtagenic Therapeutics, Inc.\new | $0 | $1,4 mill. | · | · | · | 9 |
| RCKTROCKET PHARMACEUTICALS, INC. | $0 | -$223,1 mill. | · | -60.3% | · | 10 |
| RNTXRein Therapeutics, Inc. | $0 | -$49,9 mill. | · | -139.9% | · | 11 |
| SPRBSPRUCE BIOSCIENCES, INC. | $0 | -$39,0 mill. | · | -109.2% | · | 4 |
| SYBXSYNLOGIC, INC. | $0 | -$1,0 mill. | · | -8.2% | · | 10 |
| TENXTENAX THERAPEUTICS, INC. | $0 | -$52,6 mill. | · | -55.6% | · | 8 |
| VTVTvTv Therapeutics Inc. | $0 | -$27,0 mill. | · | -70.4% | · | 13 |
| XCUREXICURE, INC. | $0 | -$4,9 mill. | · | -92.5% | · | 10 |
| ZNTLZentalis Pharmaceuticals, Inc. | $0 | -$137,1 mill. | · | -49.5% | · | 4 |
| AAPGASCENTAGE PHARMA GROUP INTERNATIONAL | CNY 980,6 mill. | -CNY 405,4 mill. | -41.4% | -249.8% | · | 3 |
| INCRIntercure Ltd. | ILS 238,8 mill. | -ILS 67,8 mill. | -30.5% | -15.9% | +93.0% | 6 |
| ZYBTZhengye Biotechnology Holding Ltd | CNY 116,4 mill. | -CNY 69,8 mill. | -71.3% | -26.1% | · | 4 |
| HYFTMindWalk Holdings Corp. | CAD 24,5 mill. | -CAD 30,2 mill. | -123.3% | -102.0% | +11.8% | 6 |
| MCUJFMEDICURE INC | CAD 21,9 mill. | -CAD 1,0 mill. | -4.7% | -5.1% | +1.7% | 10 |
| XTXXFAdastra Holdings Ltd. | CAD 13,3 mill. | -CAD 4,3 mill. | -32.2% | -21.1% | · | 3 |
| IMRNImmuron Ltd | AUD 7,3 mill. | -AUD 5,2 mill. | -71.6% | -50.2% | +23.7% | 10 |
| MMTZFMindMaze Therapeutics Holding SA | CHF 6,3 mill. | -CHF 98,2 mill. | · | -99.4% | · | 3 |
| AVCRFAvricore Health Inc. | CAD 4,7 mill. | -CAD 668.977 | -14.4% | -33.6% | · | 9 |
| ADXNAddex Therapeutics Ltd. | CHF 404.102 | CHF 7,1 mill. | · | 130.4% | -31.9% | 7 |
| GELSGelteq Ltd | AUD 165.645 | -$6,6 mill. | · | -43.0% | · | 2 |
| KZIAKAZIA THERAPEUTICS LTD | AUD 42.000 | -AUD 20,7 mill. | · | · | · | 8 |
| IFRXInflaRx N.V. | EUR 29.331 | -EUR 45,6 mill. | · | · | · | 3 |
| ALXOALX ONCOLOGY HOLDINGS INC | · | -$101,7 mill. | · | -145.7% | · | 5 |
| ANIXAnixa Biosciences Inc | · | -$10,9 mill. | · | -62.2% | · | 13 |
| APVOAptevo Therapeutics Inc. | · | -$26,0 mill. | · | -234.6% | · | 8 |
| ATHEALTERITY THERAPEUTICS LTD | · | -AUD 12,1 mill. | · | · | · | 3 |
| ATOSATOSSA THERAPEUTICS, INC. | · | -$34,8 mill. | · | -62.7% | · | 5 |
| BDRXBiodexa Pharmaceuticals Plc | · | -GBP 6,4 mill. | · | -64.7% | · | 9 |
| BETRFBetterLife Pharma Inc. | · | -CAD 9,1 mill. | · | · | · | 0 |
| BIVIBIOVIE INC. | · | -$22,1 mill. | · | -150.8% | · | 0 |
| BIXTBIOXYTRAN, INC | · | -$2,1 mill. | · | · | · | 8 |
| BNTCBenitec Biopharma Inc. | · | -$45,5 mill. | · | -33.2% | · | 6 |
| BPTHBIO-PATH HOLDINGS, INC. | · | -$9,9 mill. | · | -3325.7% | · | 8 |
| CATXPerspective Therapeutics, Inc. | · | -$103,1 mill. | · | -41.4% | · | 14 |
| CMNDClearmind Medicine Inc. | · | -$3,9 mill. | · | -179.4% | · | 0 |
| COCPCocrystal Pharma, Inc. | · | -$8,8 mill. | · | -111.4% | · | 3 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | · | -$78,5 mill. | · | -54.2% | · | 8 |
| CTXRCitius Pharmaceuticals, Inc. | · | -$39,7 mill. | · | -57.8% | · | 10 |
| CYDYCytoDyn Inc. | · | -$42,7 mill. | · | · | · | 3 |
| CYTOFAltamira Therapeutics Ltd. | · | -$8,5 mill. | · | · | · | 3 |
| DCOYDecoy Therapeutics Inc. | · | -$12,5 mill. | · | -338.3% | · | 8 |
| DMRADamora Therapeutics, Inc. | · | -$209,8 mill. | · | -163.8% | · | 0 |
| EDSAEdesa Biotech, Inc. | · | -$7,2 mill. | · | -99.6% | · | 9 |
| ELDNEledon Pharmaceuticals, Inc. | · | -$45,6 mill. | · | -63.6% | · | 5 |
| ELVNEnliven Therapeutics, Inc. | · | -$103,7 mill. | · | -27.0% | · | 0 |
| ENVBEnveric Biosciences, Inc. | · | -$8,8 mill. | · | -304.0% | · | 5 |
| EOCNGalmed Pharmaceuticals Ltd. | · | -$10,3 mill. | · | -64.2% | · | 7 |
| EQEquillium, Inc. | · | -$22,4 mill. | · | -94.0% | · | 3 |
| ERNAErnexa Therapeutics Inc. | · | -$14,1 mill. | · | -686.7% | · | 14 |
| FBRXForte Biosciences, Inc. | · | -$69,4 mill. | · | -122.3% | · | 4 |
| FLNAFILANA THERAPEUTICS, INC. | · | -$91,0 mill. | · | -82.7% | · | 5 |
| GNPXGenprex, Inc. | · | -$16,2 mill. | · | -338.7% | · | 8 |
| GTBPGT Biopharma, Inc. | · | -$28,4 mill. | · | · | · | 10 |
| HEPAHepion Pharmaceuticals, Inc. | · | -$8,3 mill. | · | · | · | 4 |
| IMNNImunon, Inc. | · | -$14,5 mill. | · | -256.4% | · | 6 |
| IMRXImmuneering Corp | · | -$56,0 mill. | · | -43.1% | · | 4 |
| INMInMed Pharmaceuticals Inc. | · | -$12,6 mill. | · | -173.1% | · | 5 |
| INTIInhibitor Therapeutics, Inc. | · | -$3,3 mill. | · | · | · | 9 |
| LITSLite Strategy, Inc. | · | -$71,2 mill. | · | -243.0% | · | 9 |
| LRMRLarimar Therapeutics, Inc. | · | -$165,7 mill. | · | -132.6% | · | 8 |
| MBIOMUSTANG BIO, INC. | · | -$1,9 mill. | · | · | · | 3 |
| MTNBMatinas BioPharma Holdings, Inc. | · | -$10,3 mill. | · | -166.6% | · | 10 |
| NBPNovaBridge Biosciences | · | -$46,3 mill. | · | -21.4% | · | 7 |
| NERVMinerva Neurosciences, Inc. | · | -$293,4 mill. | · | · | · | 8 |
| NIKANIKA PHARMACEUTICALS, INC | · | -$76.398 | · | · | · | 4 |
| NMADNOMAD POWER SOLUTIONS, INC. | · | -$6,1 mill. | · | -115.9% | · | 5 |
| OGENORAGENICS INC | · | -$9,8 mill. | · | · | · | 12 |
| OMEROMEROS CORP | · | -$3,4 mill. | · | · | · | 12 |
| ORKAOruka Therapeutics, Inc. | · | -$105,4 mill. | · | -22.3% | · | 10 |
| OTLCOncotelic Therapeutics, Inc. | · | $249,3 mill. | · | 184.0% | · | 4 |
| PHIOPhio Pharmaceuticals Corp. | · | -$8,7 mill. | · | -69.9% | · | 8 |
| PKTXProtoKinetix, Inc. | · | -$393.650 | · | -123.0% | · | 5 |
| PPBTPURPLE BIOTECH LTD. | · | -$26,4 mill. | · | -124.0% | · | 4 |
| PULMPulmatrix, Inc. | · | -$5,2 mill. | · | -80.9% | · | 12 |
| PVLAPALVELLA THERAPEUTICS, INC. | · | -$41,7 mill. | · | -92.1% | · | 11 |
| QNRXQuoin Pharmaceuticals Ltd. | · | -$15,8 mill. | · | -141.6% | · | 3 |
| QNTMQuantum Biopharma Ltd. | · | · | · | · | · | 1 |
| SLSSELLAS Life Sciences Group, Inc. | · | -$26,9 mill. | · | -66.9% | · | 7 |
| SNGXSOLIGENIX, INC. | · | -$11,1 mill. | · | -235.5% | · | 15 |
| SVRASavara Inc | · | -$118,8 mill. | · | -63.5% | · | 9 |
| TLSATiziana Life Sciences Ltd | · | -$11,9 mill. | · | -250.5% | · | 0 |
| TPSTTempest Therapeutics, Inc. | · | -$26,3 mill. | · | -203.6% | · | 5 |
| TRFATRAFALGAR INTERNATIONAL, INC. | · | -$331.612 | · | · | · | 5 |
| TVRDTvardi Therapeutics, Inc. | · | -$18,2 mill. | · | · | · | 13 |
| VERUVERU INC. | · | -$22,7 mill. | · | -89.7% | · | 16 |
| XBITXBiotech Inc. | · | -$45,5 mill. | · | -28.2% | · | 6 |
| XRTXXORTX Therapeutics Inc. | · | -CAD 1,7 mill. | · | -18.4% | · | 0 |
| VREOFVireo Growth Inc. | $268,8 mill. | -$68,1 mill. | -25.3% | -37.5% | +40.4% | 6 |
| SEPNSepterna, Inc. | $46,0 mill. | -$48,9 mill. | -106.4% | -12.2% | · | 3 |
| BFRIBiofrontera Inc. | $41,7 mill. | -$10,5 mill. | -25.3% | -141.3% | +17.2% | 6 |
| BHSTBIOHARVEST SCIENCES INC. | $34,5 mill. | -$11,1 mill. | -32.3% | -83.2% | · | 3 |
| TRDAEntrada Therapeutics, Inc. | $25,4 mill. | -$143,8 mill. | -565.5% | -39.1% | · | 3 |
| ZBIOZenas BioPharma, Inc. | $10,0 mill. | -$377,7 mill. | · | -136.2% | · | 3 |
| COYACoya Therapeutics, Inc. | $7,9 mill. | -$21,2 mill. | -267.1% | -51.4% | · | 4 |
| BOLTBolt Biotherapeutics, Inc. | $7,7 mill. | -$33,4 mill. | -433.7% | -79.7% | +101.6% | 6 |
| CAMPCamp4 Therapeutics Corp | $3,5 mill. | -$80,4 mill. | · | -145.1% | · | 3 |
| UPBUpstream Bio, Inc. | $2,9 mill. | -$143,4 mill. | · | -35.4% | · | 3 |
| LGVNLongeveron Inc. | $1,2 mill. | -$22,7 mill. | · | -164.7% | -26.6% | 6 |
| BSPKBespoke Extracts, Inc. | $1,1 mill. | -$1,0 mill. | · | · | · | 6 |
| SXTP60 DEGREES PHARMACEUTICALS, INC. | $1,0 mill. | -$7,4 mill. | -732.8% | -196.4% | · | 4 |
| ONCOOnconetix, Inc. | $815.371 | -$14,0 mill. | · | -115.5% | · | 3 |
| ELABPMGC Holdings Inc. | $590.084 | -$7,7 mill. | -1313.0% | -106.9% | · | 3 |
| LIPOLIPELLA PHARMACEUTICALS INC. | $536.357 | -$5,0 mill. | -935.2% | -198.1% | · | 4 |
| HINDVyome Holdings, Inc | $319.714 | -$10,3 mill. | · | · | -51.0% | 12 |
| BFRGBullFrog AI Holdings, Inc. | $116.670 | -$6,5 mill. | · | -183.0% | · | 3 |
| CNTBConnect Biopharma Holdings Ltd | $64.000 | -$55,5 mill. | · | -82.7% | · | 3 |
| HCWBHCW Biologics Inc. | $54.232 | -$8,0 mill. | · | · | · | 6 |
| KAYSKaya Holdings, Inc. | $7.134 | -$2,1 mill. | · | · | -62.9% | 11 |
| AZTRAzitra, Inc. | $0 | -$11,0 mill. | · | -230.7% | · | 4 |
| BRNSBarinthus Biotherapeutics plc. | $0 | -$66,4 mill. | · | -65.0% | · | 6 |
| CNBXCNBX Pharmaceuticals Inc. | $0 | -$313.976 | · | · | · | 11 |
| EPRXEUPRAXIA PHARMACEUTICALS INC. | $0 | -$38,6 mill. | · | -66.8% | · | 3 |
| OGIORGANIGRAM GLOBAL INC. | CAD 159,8 mill. | -CAD 45,4 mill. | -28.4% | -14.9% | · | 6 |
| PYRGFPyroGenesis Canada Inc. | CAD 19,0 mill. | -CAD 32,2 mill. | -169.2% | -111.6% | · | 4 |
| CTORCITIUS ONCOLOGY, INC. | · | -$24,8 mill. | · | -54.4% | · | 0 |
| ELTXElicio Therapeutics, Inc. | · | -$39,6 mill. | · | · | · | 3 |
| GANXGain Therapeutics, Inc. | · | -$20,2 mill. | · | -155.7% | · | 4 |
| KTTAPasithea Therapeutics Corp. | · | -$20,4 mill. | · | -58.4% | · | 2 |
| MAIAMAIA Biotechnology, Inc. | · | -$22,4 mill. | · | -745.2% | · | 3 |
| NXTSNexentis Technologies Inc. | · | -$4,0 mill. | · | -38.6% | · | 7 |
| PCSAProcessa Pharmaceuticals, Inc. | · | -$13,6 mill. | · | -373.0% | · | 7 |
| PTPIPetros Pharmaceuticals, Inc. | · | $1,9 mill. | · | · | · | 5 |
| VBIOValion Bio, Inc. | · | -$8,9 mill. | · | -91.8% | · | 4 |
«·» marca una cifra no disponible en nuestros datos.